SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-17-001388
Filing Date
2017-05-03
Accepted
2017-05-03 16:05:43
Documents
2
Period of Report
2017-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CLOVIS ONCOLOGY, INC. 8-K a51552708.htm 8-K 17663
2 EXHIBIT 99.1 a51552708ex99_1.htm EX-99.1 59535
  Complete submission text file 0001157523-17-001388.txt   78334
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35347 | Film No.: 17809113
SIC: 2834 Pharmaceutical Preparations